Pharmacokinetics After Oral Intake
6
1
1
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (6)
A Comparison of the Pharmacokinetic Properties of ARN-75039 Tablets With Excipients to Neat ARN-75039 in Hydroxypropyl Methylcellulose (HPMC) Capsules in Healthy Adult Participants Under Fed Conditions
Pharmacokinetics of Sulopenem Etzadroxil Plus Probenecid in Adolescents
Comparison of Curcumin Bioavailability
Oral Bioavailability and Bioactivity of Prenylflavonoids From Hops
Bioavailability of Resveratrol From Vineatrol30 Extract Incorporated Into Micelles
Absorption and Excretion Kinetics of the Bioactive Ingredients of Rice Bran Extract